Foghorn Therapeutics Inc.(FHTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

FHTX Foghorn Therapeutics Inc.

盘前交易 12-20 09:19:15 EST

4.98

+0.07

+1.43%

最高5.12	最低4.69	成交量32.70万
今开4.84	昨收4.91	日振幅8.76%
总市值2.77亿	流通市值1.30亿	总股本5,559万
成交额162.42万	换手率1.26%	流通股本2,605万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"FHTX","market":"US","secType":"STK","nameCN":"Foghorn Therapeutics Inc.","latestPrice":4.98,"timestamp":1734642000000,"preClose":4.91,"halted":0,"volume":326985,"delay":0,"floatShares":26054176,"shares":55593131,"eps":-1.834007,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.07,"latestTime":"12-20 09:19:15 EST","open":4.84,"high":5.12,"low":4.69,"amount":1624179.095754,"amplitude":0.087576,"askPrice":5.29,"askSize":26,"bidPrice":4.71,"bidSize":22,"shortable":3,"etf":0,"ttmEps":-1.834007,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734705000000},"adr":0,"listingDate":1603425600000,"adjPreClose":4.98,"postHourTrading":{"tag":"盘后","latestPrice":4.98,"preClose":4.98,"latestTime":"16:20 EST","volume":671,"amount":3341.58,"timestamp":1734643200240},"volumeRatio":0.9510243452865117,"impliedVol":2.7279,"impliedVolPercentile":0.988},"requestUrl":"/m/hq/s/FHTX/wiki","defaultTab":"wiki","newsList":[{"id":"2492513270","title":"Foghorn Therapeutics Inc.盘中异动 下午盘股价大跌5.26%报5.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492513270","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492513270?lang=zh_cn&edition=full","pubTime":"2024-12-19 02:19","pubTimestamp":1734545960,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日02时19分，Foghorn Therapeutics Inc.股票出现异动，股价快速下挫5.26%。截至发稿，该股报5.22美元/股，成交量7.5268万股，换手率0.14%，振幅8.47%。Foghorn Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.80%。Foghorn Therapeutics Inc.公司简介：Foghorn Therapeutics Inc 致力于发现和开发一类新的药物，这些药物针对染色质调节系统中基因决定的依赖性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121902192095ea581d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121902192095ea581d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FHTX","BK4139","LENZ"],"gpt_icon":0},{"id":"2491740692","title":"Foghorn Therapeutics Inc.股价重挫11.32% 市值跌2957.78万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491740692","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491740692?lang=zh_cn&edition=full","pubTime":"2024-12-16 22:30","pubTimestamp":1734359444,"startTime":"0","endTime":"0","summary":"北京时间2024年12月16日22时30分，Foghorn Therapeutics Inc.股票出现异动，股价快速跳水11.32%。截至发稿，该股报4.70美元/股，成交量4.447万股，换手率0.08%，振幅0.00%。Foghorn Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Foghorn Therapeutics Inc.公司简介：Foghorn Therapeutics Inc 致力于发现和开发一类新的药物，这些药物针对染色质调节系统中基因决定的依赖性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121622304495ea132c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121622304495ea132c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","FHTX"],"gpt_icon":0},{"id":"2491984896","title":"BUZZ-Foghorn 停止独立开发癌症疗法后业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2491984896","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491984896?lang=zh_cn&edition=full","pubTime":"2024-12-16 20:48","pubTimestamp":1734353333,"startTime":"0","endTime":"0","summary":"12月16日 -  ** 药物开发商 Foghorn Therapeutics FHTX.O股价在盘前交易中下跌 37.2% 至 3.33 美元  ** 公司表示将停止其实验性药物FHD-286的独立开发，该药物将与化疗药物联合使用，治疗一种血癌患者。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241216:nL4T3NH0WE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FHTX","BK4139"],"gpt_icon":0},{"id":"2491555379","title":"Foghorn Therapeutics Inc.盘中异动 股价大跌5.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491555379","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491555379?lang=zh_cn&edition=full","pubTime":"2024-12-13 22:53","pubTimestamp":1734101604,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日22时53分，Foghorn Therapeutics Inc.股票出现异动，股价快速下挫5.71%。Foghorn Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.36%。其相关个股中，Oculis Holding Ag C/Wts 06/03/2028 、Barinthus Biotherapeutics Plc、Mesoblast Ltd涨幅较大，Palisade Bio, Inc.、Aptevo Therapeutics Inc.、Candel Therapeutics, Inc.较为活跃，换手率分别为32.82%、24.96%、23.70%，振幅较大的相关个股有Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Tc Biopharm  Plc C/Wts 10/02/2028 、Os Therapies Incorporated，振幅分别为42.56%、39.33%、26.29%。Foghorn Therapeutics Inc.公司简介：Foghorn Therapeutics Inc 致力于发现和开发一类新的药物，这些药物针对染色质调节系统中基因决定的依赖性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121322532495e977e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121322532495e977e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FHTX","LENZ","BK4139"],"gpt_icon":0},{"id":"2489463459","title":"Foghorn Therapeutics Inc.盘中异动 快速下跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489463459","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489463459?lang=zh_cn&edition=full","pubTime":"2024-12-05 23:23","pubTimestamp":1733412228,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日23时23分，Foghorn Therapeutics Inc.股票出现异动，股价快速跳水5.01%。Foghorn Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.40%。其相关个股中，Protara Therapeutics, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Molecular Templates, Inc.涨幅较大，Psyence Biomedical Ltd.、Molecular Templates, Inc.、Protara Therapeutics, Inc.较为活跃，换手率分别为2203.12%、852.45%、365.30%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Protara Therapeutics, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为109.61%、101.13%、84.26%。Foghorn Therapeutics Inc.公司简介：Foghorn Therapeutics Inc 致力于发现和开发一类新的药物，这些药物针对染色质调节系统中基因决定的依赖性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205232349a1d6b596&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205232349a1d6b596&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FHTX","BK4139","LENZ"],"gpt_icon":0},{"id":"2488113414","title":"Foghorn Therapeutics Inc.盘中异动 股价大跌5.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488113414","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488113414?lang=zh_cn&edition=full","pubTime":"2024-12-04 23:33","pubTimestamp":1733326403,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日23时33分，Foghorn Therapeutics Inc.股票出现异动，股价快速跳水5.51%。Foghorn Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.09%。其相关个股中，Cyclerion Therapeutics, Inc.、Exicure, Inc.、Heron Therapeutics, Inc.涨幅较大，Cyclerion Therapeutics, Inc.、Can Fite Biopharma Ltd、Windtree Therapeutics, Inc.较为活跃，换手率分别为2799.82%、237.06%、125.13%，振幅较大的相关个股有Cyclerion Therapeutics, Inc.、Apollomics Inc C/Wts 01/04/2028 、Eterna Therapeutics Inc.，振幅分别为237.89%、61.32%、55.22%。Foghorn Therapeutics Inc.公司简介：Foghorn Therapeutics Inc 致力于发现和开发一类新的药物，这些药物针对染色质调节系统中基因决定的依赖性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204233324a26c7d90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204233324a26c7d90&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FHTX","LENZ"],"gpt_icon":0},{"id":"2488072973","title":"Foghorn Therapeutics Inc.盘中异动 临近收盘急速跳水5.11%报7.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488072973","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488072973?lang=zh_cn&edition=full","pubTime":"2024-12-04 04:41","pubTimestamp":1733258480,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日04时41分，Foghorn Therapeutics Inc.股票出现波动，股价快速跳水5.11%。截至发稿，该股报7.62美元/股，成交量9.8875万股，换手率0.18%，振幅5.35%。Foghorn Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为1.03%。Foghorn Therapeutics Inc.公司简介：Foghorn Therapeutics Inc 致力于发现和开发一类新的药物，这些药物针对染色质调节系统中基因决定的依赖性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120404412098e52ab6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120404412098e52ab6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","FHTX"],"gpt_icon":0},{"id":"2488770346","title":"Foghorn Therapeutics Inc.盘中异动 早盘快速上涨5.26%报8.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488770346","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488770346?lang=zh_cn&edition=full","pubTime":"2024-12-02 22:41","pubTimestamp":1733150492,"startTime":"0","endTime":"0","summary":"北京时间2024年12月02日22时41分，Foghorn Therapeutics Inc.股票出现异动，股价快速上涨5.26%。截至发稿，该股报8.41美元/股，成交量6576股，换手率0.01%，振幅1.75%。Foghorn Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Foghorn Therapeutics Inc.公司简介：Foghorn Therapeutics Inc 致力于发现和开发一类新的药物，这些药物针对染色质调节系统中基因决定的依赖性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202224132a2669eb0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202224132a2669eb0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FHTX","BK4139","LENZ"],"gpt_icon":0},{"id":"2486080009","title":"Foghorn Therapeutics Inc.盘中异动 早盘大幅上涨6.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486080009","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486080009?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:37","pubTimestamp":1732545467,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时37分，Foghorn Therapeutics Inc.股票出现异动，股价急速上涨6.25%。Foghorn Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为1.36%。其相关个股中，Scholar Rock Holding Corporation、Bridgebio Pharma, Inc.、60 Degrees Pharmaceuticals, Inc.涨幅较大，Cognition Therapeutics, Inc.、木薯科学、Citius Pharmaceuticals, Inc.较为活跃，换手率分别为90.25%、66.76%、41.55%，振幅较大的相关个股有Kodiak Sciences Inc、Werewolf Therapeutics, Inc.、Anixa Biosciences, Inc.，振幅分别为106.46%、105.79%、105.63%。Foghorn Therapeutics Inc.公司简介：Foghorn Therapeutics Inc 致力于发现和开发一类新的药物，这些药物针对染色质调节系统中基因决定的依赖性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223747971a85e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223747971a85e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FHTX","LENZ"],"gpt_icon":0},{"id":"2485973252","title":"Foghorn Therapeutics Inc.盘中异动 急速拉升5.96%报8.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485973252","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485973252?lang=zh_cn&edition=full","pubTime":"2024-11-23 02:09","pubTimestamp":1732298982,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日02时09分，Foghorn Therapeutics Inc.股票出现波动，股价大幅上涨5.96%。截至发稿，该股报8.18美元/股，成交量3.0544万股，换手率0.05%，振幅7.12%。Foghorn Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.67%。Foghorn Therapeutics Inc.公司简介：Foghorn Therapeutics Inc 致力于发现和开发一类新的药物，这些药物针对染色质调节系统中基因决定的依赖性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112302094298e4436e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112302094298e4436e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FHTX","LENZ","BK4139"],"gpt_icon":0},{"id":"2484718176","title":"Foghorn Therapeutics Inc.盘中异动 大幅跳水5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484718176","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484718176?lang=zh_cn&edition=full","pubTime":"2024-11-18 23:01","pubTimestamp":1731942063,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日23时01分，Foghorn Therapeutics Inc.股票出现波动，股价急速跳水5.12%。Foghorn Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.62%。其相关个股中，Hcw Biologics Inc.、Apollomics Inc C/Wts 01/04/2028 、冠科美博涨幅较大，Tharimmune, Inc.、Hcw Biologics Inc.、冠科美博较为活跃，换手率分别为550.48%、434.83%、313.67%，振幅较大的相关个股有Hcw Biologics Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、冠科美博，振幅分别为118.81%、71.83%、69.86%。Foghorn Therapeutics Inc.公司简介：Foghorn Therapeutics Inc 致力于发现和开发一类新的药物，这些药物针对染色质调节系统中基因决定的依赖性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118230103971a732f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118230103971a732f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","FHTX"],"gpt_icon":0},{"id":"2482267886","title":"Foghorn Therapeutics Inc.2024财年第三财季实现净利润-19.12百万美元，同比减少33.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482267886","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482267886?lang=zh_cn&edition=full","pubTime":"2024-11-11 00:00","pubTimestamp":1731254422,"startTime":"0","endTime":"0","summary":"11月11日，Foghorn Therapeutics Inc.公布财报，公告显示公司2024财年第三财季净利润为-19.12百万美元，同比减少33.24%；其中营业收入为7.81百万美元，同比减少55.32%，每股基本收益为-0.31美元。机构评级：截至2024年11月11日，当前有6家机构对Foghorn Therapeutics Inc.目标价做出预测，其中目标均价为16.00美元，其中最低目标价为9.00美元，最高目标价为20.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111000031a229e370&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111000031a229e370&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FHTX","LENZ"],"gpt_icon":0},{"id":"2481533885","title":"Foghorn Therapeutics Inc.盘中异动 早盘股价大涨5.30%报8.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481533885","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481533885?lang=zh_cn&edition=full","pubTime":"2024-11-04 23:56","pubTimestamp":1730735818,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日23时56分，Foghorn Therapeutics Inc.股票出现异动，股价急速拉升5.30%。截至发稿，该股报8.74美元/股，成交量1.8417万股，换手率0.03%，振幅7.32%。Foghorn Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.41%。Foghorn Therapeutics Inc.公司简介：Foghorn Therapeutics Inc 致力于发现和开发一类新的药物，这些药物针对染色质调节系统中基因决定的依赖性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110423565898e40510&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110423565898e40510&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","FHTX"],"gpt_icon":0},{"id":"2480349318","title":"Foghorn Therapeutics Inc.盘中异动 急速上涨5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480349318","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480349318?lang=zh_cn&edition=full","pubTime":"2024-11-02 00:36","pubTimestamp":1730478999,"startTime":"0","endTime":"0","summary":"北京时间2024年11月02日00时36分，Foghorn Therapeutics Inc.股票出现波动，股价急速拉升5.38%。截至发稿，该股报8.03美元/股，成交量1.4092万股，换手率0.03%，振幅2.97%。Foghorn Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.62%。Foghorn Therapeutics Inc.公司简介：Foghorn Therapeutics Inc 致力于发现和开发一类新的药物，这些药物针对染色质调节系统中基因决定的依赖性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241102003640971a3e8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241102003640971a3e8e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","FHTX"],"gpt_icon":0},{"id":"2479346620","title":"Foghorn Therapeutics Inc.盘中异动 早盘股价大跌5.10%报7.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479346620","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479346620?lang=zh_cn&edition=full","pubTime":"2024-10-31 22:52","pubTimestamp":1730386355,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日22时52分，Foghorn Therapeutics Inc.股票出现异动，股价大幅下挫5.10%。截至发稿，该股报7.63美元/股，成交量1.1025万股，换手率0.02%，振幅3.67%。Foghorn Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为3.40%。Foghorn Therapeutics Inc.公司简介：Foghorn Therapeutics Inc 致力于发现和开发一类新的药物，这些药物针对染色质调节系统中基因决定的依赖性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031225235ab8bf402&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031225235ab8bf402&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FHTX","LENZ","BK4139"],"gpt_icon":0},{"id":"2479128874","title":"Foghorn Therapeutics Inc.  预计每股亏损44美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2479128874","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479128874?lang=zh_cn&edition=full","pubTime":"2024-10-29 21:46","pubTimestamp":1730209591,"startTime":"0","endTime":"0","summary":"   * Foghorn Therapeutics Inc.    预计将在10月31日公布截至2024年9月30日的业绩报告时显示季度收入下降(预计)    * 根据LSEG的数据，6位分析师的平均预期显示，这家总部位于马萨诸塞州剑桥市的公司预计营收将从去年同期的1748万美元下降63.7%，至633.9万美元。* LSEG 分析师对 Foghorn Therapeutics Inc. 的平均预期是每股亏损 44 美分。* 华尔街对 Foghorn Therapeutics Inc. 的 12 个月目标价中位数为 17.00 美元，高于其最新收盘价 8.11 美元。10月29日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FHTX","LENZ"],"gpt_icon":0},{"id":"2478484265","title":"Foghorn Therapeutics Inc.盘中异动 股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478484265","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478484265?lang=zh_cn&edition=full","pubTime":"2024-10-28 22:06","pubTimestamp":1730124409,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日22时06分，Foghorn Therapeutics Inc.股票出现异动，股价大幅拉升5.05%。截至发稿，该股报8.11美元/股，成交量5566股，换手率0.01%，振幅4.40%。Foghorn Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.46%。Foghorn Therapeutics Inc.公司简介：Foghorn Therapeutics Inc 致力于发现和开发一类新的药物，这些药物针对染色质调节系统中基因决定的依赖性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028220649971a2aa2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028220649971a2aa2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","FHTX"],"gpt_icon":0},{"id":"2478939569","title":"Foghorn Therapeutics Inc.盘中异动 早盘快速上涨5.10%报8.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478939569","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478939569?lang=zh_cn&edition=full","pubTime":"2024-10-25 22:07","pubTimestamp":1729865263,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日22时07分，Foghorn Therapeutics Inc.股票出现波动，股价大幅拉升5.10%。截至发稿，该股报8.03美元/股，成交量2.0969万股，换手率0.04%，振幅3.66%。Foghorn Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.74%。Foghorn Therapeutics Inc.公司简介：Foghorn Therapeutics Inc 致力于发现和开发一类新的药物，这些药物针对染色质调节系统中基因决定的依赖性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102522074398e3e844&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102522074398e3e844&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FHTX","LENZ"],"gpt_icon":0},{"id":"2477648588","title":"Foghorn Therapeutics Inc.盘中异动 股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477648588","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477648588?lang=zh_cn&edition=full","pubTime":"2024-10-21 22:45","pubTimestamp":1729521931,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日22时45分，Foghorn Therapeutics Inc.股票出现波动，股价大幅下跌5.08%。Foghorn Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.61%。其相关个股中，Genprex, Inc.、Biovie Inc.、Gri Bio, Inc.涨幅较大，Genprex, Inc.、Gri Bio, Inc.、Biovie Inc.较为活跃，换手率分别为4840.42%、2606.15%、1127.45%，振幅较大的相关个股有Genprex, Inc.、Biovie Inc.、Aptevo Therapeutics Inc.，振幅分别为265.62%、157.02%、118.79%。Foghorn Therapeutics Inc.公司简介：Foghorn Therapeutics Inc 致力于发现和开发一类新的药物，这些药物针对染色质调节系统中基因决定的依赖性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021224531ab6bbb62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021224531ab6bbb62&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","FHTX"],"gpt_icon":0},{"id":"2474097973","title":"Foghorn Therapeutics Inc.盘中异动 急速上涨5.31%报7.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474097973","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474097973?lang=zh_cn&edition=full","pubTime":"2024-10-11 22:10","pubTimestamp":1728655811,"startTime":"0","endTime":"0","summary":"北京时间2024年10月11日22时10分，Foghorn Therapeutics Inc.股票出现异动，股价快速拉升5.31%。截至发稿，该股报7.44美元/股，成交量5374股，换手率0.01%，振幅4.82%。Foghorn Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.50%。Foghorn Therapeutics Inc.公司简介：Foghorn Therapeutics Inc 致力于发现和开发一类新的药物，这些药物针对染色质调节系统中基因决定的依赖性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410112210129719faea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410112210129719faea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FHTX","LENZ","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.foghorntx.com","stockEarnings":[{"period":"1week","weight":-0.1384},{"period":"1month","weight":-0.3615},{"period":"3month","weight":-0.5015},{"period":"6month","weight":-0.0604},{"period":"1year","weight":-0.1672},{"period":"ytd","weight":-0.2279}],"compareEarnings":[{"period":"1week","weight":-0.0302},{"period":"1month","weight":-0.0071},{"period":"3month","weight":0.0314},{"period":"6month","weight":0.0764},{"period":"1year","weight":0.2517},{"period":"ytd","weight":0.2331}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Foghorn Therapeutics Inc.成立于2015年10月。该公司率先发现并开发了一类针对染色质调节系统内基因决定依赖性的药物，这是一个尚未开发的治疗机会干预。该公司专有的基因流量控制平台为其提供了一个对染色质调节系统的各个组成部分如何相互作用的综合性、机械性理解，使其能够识别、验证系统内的潜在药物靶点。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.168127},{"month":2,"riseRate":0.25,"avgChangeRate":0.179877},{"month":3,"riseRate":0.5,"avgChangeRate":0.083902},{"month":4,"riseRate":0.25,"avgChangeRate":-0.13515},{"month":5,"riseRate":0.5,"avgChangeRate":0.023401},{"month":6,"riseRate":0.75,"avgChangeRate":0.046189},{"month":7,"riseRate":0.75,"avgChangeRate":0.111947},{"month":8,"riseRate":0.5,"avgChangeRate":0.029106},{"month":9,"riseRate":0.5,"avgChangeRate":-0.069683},{"month":10,"riseRate":0.25,"avgChangeRate":-0.145474},{"month":11,"riseRate":0.6,"avgChangeRate":0.053069},{"month":12,"riseRate":0.6,"avgChangeRate":0.213248}],"exchange":"NASDAQ","name":"Foghorn Therapeutics Inc.","nameEN":"Foghorn Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Foghorn Therapeutics Inc.(FHTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Foghorn Therapeutics Inc.(FHTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Foghorn Therapeutics Inc.,FHTX,Foghorn Therapeutics Inc.股票,Foghorn Therapeutics Inc.股票老虎,Foghorn Therapeutics Inc.股票老虎国际,Foghorn Therapeutics Inc.行情,Foghorn Therapeutics Inc.股票行情,Foghorn Therapeutics Inc.股价,Foghorn Therapeutics Inc.股市,Foghorn Therapeutics Inc.股票价格,Foghorn Therapeutics Inc.股票交易,Foghorn Therapeutics Inc.股票购买,Foghorn Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Foghorn Therapeutics Inc.(FHTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Foghorn Therapeutics Inc.(FHTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}